Evidence map›Paper›PMID 36627187›Full record

ArticleGut2023

Gestational diabetes is driven by microbiota-induced inflammation months before diagnosis.

Yishay Pinto, Sigal Frishman, Sondra Turjeman, Adi Eshel, Meital Nuriel-Ohayon, Oshrit Shrossel, Oren Ziv, William Walters, Julie Parsonnet, Catherine Ley and 23 more

Open access · hybridAbstract read
In one paragraph

Article in Gut, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 2 pooled it
43.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 2 syntheses or guidelines pooled it, 142 citations in OpenAlex.

  1. Cellular and Molecular Pathophysiology of Gestational Diabetes.International journal of molecular sciences · 2024
    Pooled it
  2. Pooled it
  3. Imbalance of gut microbiota in gestational diabetes.BMC pregnancy and childbirth · 2024
    Trial
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Review
  9. Article
  10. MMP8 Promotes NETosis in Gestational Diabetes Mellitus.Antioxidants (Basel, Switzerland) · 2026
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. LASSO regression-derived first-trimester (9-14Archives of gynecology and obstetrics · 2026
    Article
  18. Article
  19. Review
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 11 institutions in 4 countries.

Yishay Pinto *Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.ORCID 0000-0002-5280-1040
Sigal Frishman *Helen Schneider Hospital for Women, Rabin Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Sondra TurjemanAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.ORCID 0000-0002-5224-1215
Adi EshelAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Meital Nuriel-OhayonAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Oshrit ShrosselDepartment of Mathematics, Bar-Ilan University, Ramat Gan, Israel.
Oren ZivAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
William WaltersDepartment of Microbiome Science, Max Planck Institute for Developmental Biology, Tubingen, Germany.ORCID 0000-0003-1716-3984
Julie ParsonnetDepartment of Medicine, Stanford University, Stanford, California, USA.
Catherine LeyDepartment of Medicine, Stanford University, Stanford, California, USA.
Elizabeth L JohnsonDivision of Nutritional Sciences, Cornell University, Ithaca, New York, USA.ORCID 0000-0002-8290-1122
Krithika KumarDivision of Nutritional Sciences, Cornell University, Ithaca, New York, USA.
Ron SchweitzerDepartment of Natural Compounds and Analytical Chemistry, Migal-Galilee Research Institute, Kiryat Shmona, Israel.
Soliman KhatibDepartment of Natural Compounds and Analytical Chemistry, Migal-Galilee Research Institute, Kiryat Shmona, Israel.ORCID 0000-0002-6762-2408
Faiga MagzalLaboratory of Human Health and Nutrition Sciences, Migal-Galilee Technology Center, Kiryat Shmona, Israel.ORCID 0000-0003-0975-1858
Efrat MullerThe Blavatnik School of Computer Science, Tel Aviv University, Tel Aviv, Israel.
Snait TamirLaboratory of Human Health and Nutrition Sciences, Migal-Galilee Technology Center, Kiryat Shmona, Israel.ORCID 0000-0002-7473-7369
Kinneret Tenenbaum-GavishHelen Schneider Hospital for Women, Rabin Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Samuli RautavaDepartment of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland.ORCID 0000-0003-0935-3593
Seppo SalminenFunctional Foods Forum, University of Turku, Turku, Finland.
Erika IsolauriDepartment of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland.ORCID 0000-0002-1635-8002
Or YarivClalit Health Services, Tel Aviv, Israel.
Yoav PeledHelen Schneider Hospital for Women, Rabin Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Eran PoranClalit Health Services, Tel Aviv, Israel.
Joseph PardoHelen Schneider Hospital for Women, Rabin Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Rony ChenHelen Schneider Hospital for Women, Rabin Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Moshe HodHelen Schneider Hospital for Women, Rabin Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Elhanan BorensteinThe Blavatnik School of Computer Science, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0003-3002-0945
Ruth E LeyDepartment of Microbiome Science, Max Planck Institute for Developmental Biology, Tubingen, Germany.
Betty SchwartzInstitute of Biochemistry, School of Nutritional Sciences Food Science and Nutrition, The School of Nutritional Sciences, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel.
Yoram LouzounDepartment of Mathematics, Bar-Ilan University, Ramat Gan, Israel.
Eran HadarHelen Schneider Hospital for Women, Rabin Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0002-3101-2827
Omry KorenAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel omry.koren@biu.ac.il.ORCID 0000-0002-7738-1337
Bar-Ilan University · ILTel Aviv University · ILMigal - Galilee Technology Center · ILClalit Health Services · ILCornell University · USMax Planck Institute for Developmental Biology · DEStanford University · USUniversity of Turku · FIHebrew University of Jerusalem · ILSanta Fe Institute · USUniversity of Helsinki · FI

Funding

Childhood infection and prevention of obesityR01HD063142 · NICHD · STANFORD UNIVERSITY · PI PARSONNET, JULIE · 2009 to 2013
$3.7M
NICHD NIH HHS R01 HD063142
6 · The paper itself

Abstract

objectiveGestational diabetes mellitus (GDM) is a condition in which women without diabetes are diagnosed with glucose intolerance during pregnancy, typically in the second or third trimester. Early diagnosis, along with a better understanding of its pathophysiology during the first trimester of pregnancy, may be effective in reducing incidence and associated short-term and long-term morbidities.

designWe comprehensively profiled the gut microbiome, metabolome, inflammatory cytokines, nutrition and clinical records of 394 women during the first trimester of pregnancy, before GDM diagnosis. We then built a model that can predict GDM onset weeks before it is typically diagnosed. Further, we demonstrated the role of the microbiome in disease using faecal microbiota transplant (FMT) of first trimester samples from pregnant women across three unique cohorts.

resultsWe found elevated levels of proinflammatory cytokines in women who later developed GDM, decreased faecal short-chain fatty acids and altered microbiome. We next confirmed that differences in GDM-associated microbial composition during the first trimester drove inflammation and insulin resistance more than 10 weeks prior to GDM diagnosis using FMT experiments. Following these observations, we used a machine learning approach to predict GDM based on first trimester clinical, microbial and inflammatory markers with high accuracy.

conclusionGDM onset can be identified in the first trimester of pregnancy, earlier than currently accepted. Furthermore, the gut microbiome appears to play a role in inflammation-induced GDM pathogenesis, with interleukin-6 as a potential contributor to pathogenesis. Potential GDM markers, including microbiota, can serve as targets for early diagnostics and therapeutic intervention leading to prevention.

Indexed as

Diabetes, GestationalMicrobiotaCytokinesFemaleHumansInflammationPregnancyPregnancy Trimester, ThirdCytokinesINTESTINAL MICROBIOLOGY

Identifiers

PMID36627187
PMCPMC10086485
OpenAlexW4315489816

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.